Trial Profile
A phase 2 study of Docetaxel oral (Oradoxel)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2018
Price :
$35
*
At a glance
- Drugs Docetaxel/encequidar (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 30 Nov 2018 New trial record
- 14 Nov 2018 According to an Athenex media release, the company plans to conduct this study in the first half of 2019.